Hep-B vax shortages

GLAXOSMITHKLINE has confirmed it is experiencing a “supply constraint” of its Twinrix Junior combined hepatitis A and hepatitis B vaccine, due to a current high demand for hepatitis-B containing vaccines in Australia.

The company expects Twinrix Junior to be back in stock by the end of Nov 2017, while Twinrix Adult is now back in stock following a recent supply issue.

There’s also an ongoing constraint on Engerix-B adult doses after recent shortages, with production now back to normal levels but some time taken to rebuild capacity.

There is an intermittent constraint of Engerix-B paediatric doses for the private market, with this issue expected to be resolved by the end of 2017, the company said.

GSK said supply of its vaccines containing hepatitis B to government programs is not impacted by the shortages.